VolitionRx launches Nu.Q Vet Cancer Test in-clinic in U.S. and Europe

VolitionRx’s Nu.Q Vet Cancer Test is now available in-clinic to veterinarians across the U.S and Europe through Antech, a veterinary diagnostics company. Antech’s in-clinic version of the Nu.Q Canine Cancer Test operates on the Element i+ Analyzer, providing veterinarians with a cancer screening tool for high-risk breeds and older dogs, at the patient side, with results in about six minutes. Volition’s original license and supply agreement was between Belgian Volition SRL and Heska, an Antech company, part of Mars Science & Diagnostics.